UnknownNot Applicable

Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

Egypt30 participantsStarted 2022-01-01

Plain-language summary

Patients with Androgenetic alopecia will be randomized into 2 groups; Group FCO2 receiving Fractional CO2 or Group FRF receiving Fractional Microneedling Radiofrequency.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • both genders are included. * Patients above 18 years old. Exclusion Criteria: * • Patients with patchy hair loss. * Patients with Telogen Effluvium or diffuse alopecia areata. * Patients with cicatricial alopecias. * Patients with associated inflammatory scalp disorders such as psoriasis or seborrheic dermatitis. * Patients with collagen vascular disorders. * Prior use of topical steroids on scalp in the previous 2 weeks. * Prior use of systemic steroids in the previous 1 month.

What they're measuring

Clinical Global improvement Assessment

Timeframe: 6months-1 year

Clinical Global improvement Assessment

Timeframe: 6months-1 year

Phototrichogram assessment.

Timeframe: months-1 year

Phototrichogram assessment.

Timeframe: 2 months

Patient satisfaction

Timeframe: 6months-1 year

Trial details

NCT IDNCT05435625

SponsorKasr El Aini Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-01

Contact for this trial

Rana Hilal, MD

2010014888 rana.hilal@kasralainy.edu.eg

View on ClinicalTrials.gov More Androgenic Alopecia trials